` 3613 (Beijing Tong Ren Tang Chinese Medicine Co Ltd) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

B
3613
vs
NOVO B

Over the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co Ltd has significantly outperformed NOVO B, delivering a return of +2% compared to the NOVO B's 55% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
3613
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

B
Intrinsic Value
10 HKD
Undervaluation 9%
Intrinsic Value
Price
NOVO B Intrinsic Value
633.5 DKK
Undervaluation 31%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
9.07 HKD
Novo Nordisk A/S
CSE:NOVO B
438.95 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
3613 vs NOVO B

3613
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
3613 vs NOVO B

3613
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

Beijing Tong Ren Tang Chinese Medicine Co Ltd
66.1%
NOVO B
84.3%

Operating Margin

Beijing Tong Ren Tang Chinese Medicine Co Ltd
35.8%
NOVO B
44.6%

Net Margin

Beijing Tong Ren Tang Chinese Medicine Co Ltd
31%
NOVO B
34.5%

FCF Margin

Beijing Tong Ren Tang Chinese Medicine Co Ltd
-23.8%
NOVO B
24.5%

ROE

Beijing Tong Ren Tang Chinese Medicine Co Ltd
12.6%
NOVO B
88.1%

ROA

Beijing Tong Ren Tang Chinese Medicine Co Ltd
11.1%
NOVO B
26.6%

ROIC

Beijing Tong Ren Tang Chinese Medicine Co Ltd
23%
NOVO B
30.4%

ROCE

Beijing Tong Ren Tang Chinese Medicine Co Ltd
13.7%
NOVO B
70%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
3613 vs NOVO B

Loading
3613
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
3613 vs NOVO B

Loading
3613
NOVO B
Difference
www.alphaspread.com

Performance By Year
3613 vs NOVO B

Loading
3613
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 3613 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account